Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Hur
Discontinuation and Switching Patterns of Tumour Necrosis Factor Inhibitors (TNFis) in TNFi-naive and TNFi-experienced Patients With Psoriatic Arthritis: An Observational Study From the US-based Corrona Registry
RMD Open
Rheumatology
Allergy
Immunology
Related publications
Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Arthritis Care and Research
Rheumatology
Temporomandibular Disorders in Psoriasis Patients With and Without Psoriatic Arthritis: An Observational Study
International Journal of Medical Sciences
Medicine
Smoking Status and Cause-Specific Discontinuation of Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis
Arthritis Research & Therapy
The Duration of Remission and Minimal Disease Activity After Initiation and Discontinuation of Biological Agents in Patients With Early Psoriatic Arthritis (Data From the All-Russian Psoriatic Arthritis Registry)
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Weight Loss and Achievement of Minimal Disease Activity in Patients With Psoriatic Arthritis Starting Treatment With Tumour Necrosis Factor Α Blockers
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Characterization of Insufficient Responders to Anti-Tumor Necrosis Factor Therapies in Patients With Moderate to Severe Psoriasis: Real-World Data From the US Corrona Psoriasis Registry
Journal of Dermatological Treatment
Dermatology
Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors in the Phase III, Randomised Controlled Trial: OPAL Beyond
RMD Open
Rheumatology
Allergy
Immunology
Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients With Psoriasis: An Observational and Epidemiological Study
International Journal of Inflammation
Allergy
Immunology
